A novel prothrombotic role of proprotein convertase subtilisin kexin 9: the generation of procoagulant extracellular vesicles by human mononuclear cells-Reference-Cited by-同舟云学术

A novel prothrombotic role of proprotein convertase subtilisin kexin 9: the generation of procoagulant extracellular vesicles by human mononuclear cells

Published:2022-04-12 Issue:5 Volume:49 Page:4129-4134
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Scalise Valentina,Lombardi Stefania,Sanguinetti Chiara,Nieri Dario,Pedrinelli Roberto,Celi Alessandro^ORCID,Neri Tommaso

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-022-07433-x.pdf

Reference25 articles.

1. Barale C, Melchionda E, Morotti A, Russo I (2021) PCSK9 biology and its role in atherothrombosis. Int J Mol Sci 22:5880

2. Abifadel M et al (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34:154–156

3. Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354:1264–1272

4. Navarese EP, Kołodziejczak M, Dimitroulis D, Wolff G, Busch HL, Devito F, Sionis A, Ciccone MM (2016) From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications. Eur Heart J Cardiovasc Pharmacother 2:44–53

5. Cao YX, Jin JL, Sun D, Liu HH, Guo YL, Wu NQ, Xu RX, Zhu CG, Dong Q, Sun J, Li JJ (2019) Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy. J Transl Med 17:367

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease;Respiratory Medicine;2024-03

2. The Anti-Thrombotic Effects of PCSK9 Inhibitors;Pharmaceuticals;2023-08-22

3. Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review;Frontiers in Cardiovascular Medicine;2023-06-12

4. PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials;BMJ Open;2022-11